FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, specifically to a new biologically active compound – peptide Ac-Ala-Trp-Lys-Val-Leu-Ser-Pro-Gln-Gly-Gly-Gly-Pro-Trp-Asp-Ser-Val-Ala-NH2, having a longer therapeutic effect against Alzheimer's disease.
EFFECT: longer therapeutic effect against Alzheimer's disease.
1 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE HAVING CURATIVE EFFECT AGAINST ALZHEIMER DISEASE | 2014 |
|
RU2558242C1 |
| PEPTIDE WITH TREATMENT ACTION AGAINST ALZHEIMER'S DISEASE | 2016 |
|
RU2626972C2 |
| PEPTIDE WITH PROTECTIVE ACTION AGAINST ALZHEIMER'S DISEASE | 2008 |
|
RU2372355C1 |
| PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES AGAINST OLIGOMERIC FORM OF NUCLEOPHOSMIN IN TUMOUR CELLS | 2009 |
|
RU2401275C1 |
| PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES HAVING EFFECT ON SURVIVIN IN TUMOUR TISSUE | 2009 |
|
RU2396277C1 |
| PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES AGAINST MONOMERIC FORM OF NUCLEOPHOSMIN IN TUMOUR CELLS | 2009 |
|
RU2401274C1 |
| METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
| CATIONIC PEPTIDE EXHIBITING ANTIBACTERIAL PROPERTIES | 2021 |
|
RU2778856C1 |
| CODING THE HYBRID PROTEIN RECOMBINANT PLASMID DNA PERIG-PGS, ABLE TO AUTOCATALIC SPLITTING WITH FORMATION OF THE PIGASTINE ANTI-ANGIOGENIC PEPTIDE - DERIVATIVE OF THE HUMAN PIGMENTAL EPITHELY GROWTH FACTOR FRAGMENT [44-77], STRAIN ESCHERICHIA COLI BL21(DE3)/PERIG-PGS - PRODUCER OF THE SAID PROTEIN, AND THE RECOMBINANT ANTI-ANGIOGENIC PEPTIDE PRODUCTION METHOD | 2017 |
|
RU2664199C1 |
| PEPTIDE HAVING LYNX1 PROTEIN ACTIVITY (EMBODIMENTS), PHARMACEUTICAL COMPOSITION FOR TREATING ANXIETY DISORDERS AND DEPRESSION OR CORRECTION OF COGNITIVE DISORDERS IN NEURODEGENERATIVE DISEASES, CONTAINING SAID PEPTIDE, AND METHOD OF TREATING AND CORRECTING SAID DISORDERS | 2020 |
|
RU2734649C1 |
